Current vaccine strains show high neutralization against the latest variants, but the LP.8.1 antigen may provide similar or moderately higher cross-reactive antibody response.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
Of 1,981 COVID-positive women, 44.0% developed long COVID, of whom 87.0% reported symptoms lasting at least 2 months.
Early in COVID-19, rates of lung and breast cancer screenings among Medicare enrollees were 24% and 17%, respectively, below expected rates, rising to -14% and -4% later on.
The more transmissible XBB.1.5 Omicron subvariant continues to gain ground in all US regions.
The Centers for Innovation in Advanced Development and Manufacturing had difficulty reliably producing larger drug product amounts.
Overall 2-dose protection against Omicron-related hospitalization or death remained above 70% for at least 6 months.
The global vaccination rate in 2022 for people older than 60 was 76%, but it was only 33% in low-income countries.
Retail-pharmacy (non-VA) dispensing of the unproven COVID-19 treatment "potentially harmed patients while resulting in wasteful insurer spending."
COVID-19 cases have declined 78% worldwide over the past 28 days, but deaths rose 65% over the same period, the WHO says.
Scientists have identified the Alpha, Gamma, and Delta variants in white-tailed deer well after they caused widespread COVID-19 in people.
The change won't immediately impact vaccine or treatment access or FDA emergency use status.
